Trending
January 14, 2025 Neomorph Appoints Dr. Klaus Wagner as Chief Medical OfficerJanuary 14, 2025 Denbright Dental Labs Appoints Greg Minzenmayer as Chief Commercial OfficerJanuary 13, 2025 David P. King Appointed to Truvian Advisory BoardJanuary 12, 2025 Immunis Closes $25 Million Series A-1January 10, 2025 Light Horse Therapeutics Raises $62M in Series A
Featured
January 14, 2025
Neomorph Appoints Dr. Klaus Wagner as Chief Medical Officer
SAN DIEGO, Jan. 14, 2025 /PRNewswire/ -- Neomorph, Inc., today announced the appointment of Dr. Klaus Wagner as... Read more »
January 14, 2025
Denbright Dental Labs Appoints Greg Minzenmayer as Chief Commercial Officer
EL DORADO HILLS, Calif.--(BUSINESS WIRE)--O2 Investment Partners (www.o2investment.com) is pleased to announce that... Read more »
January 13, 2025
David P. King Appointed to Truvian Advisory Board
SAN DIEGO--(BUSINESS WIRE)--Truvian Health (“Truvian”) today announced the appointment of David P... Read more »